drug interactions
Showing 1 - 25 of >10,000
Stroke Sequelae, Stroke Trial in Anyang-si (NDC-002)
Completed
- Stroke Sequelae
- Stroke
-
Anyang-si, Korea, Republic ofInsan Medical Foundation Metro Hospital
Oct 22, 2023
Healthy Trial in Québec (Camlipixant + Gemfibrozil, Dabigatran etexilate + camlipixant)
Not yet recruiting
- Healthy
- Camlipixant + Gemfibrozil
- Dabigatran etexilate + camlipixant
-
Québec, Quebec, CanadaSyneos Health
Jul 17, 2023
Healthy Trial in Soeul (DA-8010 5mg, Paroxetine 20mg, Mirabegron 50mg)
Not yet recruiting
- Healthy
- DA-8010 5mg
- +2 more
-
Soeul, Korea, Republic ofSeoul National University Hospital
Aug 7, 2023
Diabetes Trial in Seongnam-si (BR3006-1, BR3006-2, BR3006-3)
Not yet recruiting
- Diabetes Mellitus
- BR3006-1
- +2 more
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center(CBMC)
Jul 17, 2023
Overweight Subjects, Obese Subjects Trial in Beijing (metformin, digoxin, IBI362)
Not yet recruiting
- Overweight Subjects
- Obese Subjects
- metformin
- +4 more
-
Beijing, Beijing, ChinaAerospace Center Hospital
Apr 4, 2023
Drug-drug Interaction Trial in Seoul (DWC202211 100mg, DWC202212 5mg, DWC202211 100mg + DWC202212 5mg)
Not yet recruiting
- Drug-drug Interaction
- DWC202211 100mg
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 24, 2023
Healthy Volunteers Trial in Madison (AMG 510, Metformin)
Completed
- Healthy Volunteers
- AMG 510
- Metformin
-
Madison, WisconsinCovance Clinical Research Unit
Jan 9, 2023
Healthy Volunteers Trial in Beijing (GP681, Rosuvastatin, Digoxin)
Recruiting
- Healthy Volunteers
- GP681
- +4 more
-
Beijing, ChinaChina-Japan Friendship Hospital
Mar 28, 2023
Healthy Male Volunteers Trial (HGP1607, HGP1501, HGP1607+HGP1501)
Completed
- Healthy Male Volunteers
- HGP1607
- +2 more
-
Seoul, Korea, Republic ofSeoul Asan Hospital
Nov 7, 2022
Drug Interaction Potentiation Trial in Seoul (Ilaprazole, Aceclofenac)
Not yet recruiting
- Drug Interaction Potentiation
-
Seoul, Korea, Republic ofSeverance Hospital
Sep 23, 2022
Drug-drug Interactions in Patients Treated With Anticancer
Recruiting
- Prostatic Neoplasm
- data collection
-
Besançon, FranceCentre Hospitalier Universitaire de Besançon
Nov 9, 2022
Arthritis, Rheumatoid, Interaction Trial in Esbjerg, Odense, Sønderborg (Tocilizumab, Sarilumab)
Terminated
- Arthritis, Rheumatoid
- Interaction
-
Esbjerg, Region Of Southern Denmark, Denmark
- +2 more
Jan 20, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)
Recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- TPX-0005
- +3 more
-
Canton, OhioGabrail Cancer Research Center
Apr 25, 2023
Idiopathic Pulmonary Fibrosis Trial in Shanghai (HEC585, Pirfenidone, Nintedanib)
Completed
- Idiopathic Pulmonary Fibrosis
- HEC585
- +2 more
-
Shanghai, ChinaShanghai Xuhui Central Hospital
May 12, 2022
Drug Interactions Trial in Gyeonggi-do (Methotrexate Sodium, Rifampicin)
Enrolling by invitation
- Drug Interactions
- Methotrexate Sodium
- Rifampicin
-
Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Oct 25, 2023
Drug Interaction Potentiation Trial in Seoul (Ilaprazole, Naproxen, Aceclofenac)
Recruiting
- Drug Interaction Potentiation
- Ilaprazole
- +3 more
-
Seoul, Korea, Republic ofSeverance Hospital
Aug 7, 2022
Epilepsy Trial in Spain, United Kingdom (GWP42003-P 20 mg/kg/Day Dose, Placebo, Clobazam)
Completed
- Epilepsy
- GWP42003-P 20 mg/kg/Day Dose
- +2 more
-
Barcelona, Spain
- +5 more
Sep 22, 2022
Gout Trial in Qingdao (Colchicine)
Recruiting
- Gout
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
May 6, 2022